Highest development stage: Marketed

Development status: Inactive

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Gatifloxacin was developed as a broad spectrum antibiotic for a number of different infections including STIs, RTIs and eye disorders (3)

Reason dropped: Withdrawn from market due to hypo- and hyper- glycaemia (2)

Additional information: Hori S, Kanemitsu K, Shimada J. Inhibitory activity of AM-1155, a newly synthesized quinolone, on gamma aminobutyric acid receptor binding. 32nd-ICAAC 1992;277